Home > The Reitox network: frequently asked questions.

European Union Drugs Agency. (2026) The Reitox network: frequently asked questions.

This is the latest version of this item.

External website: https://www.euda.europa.eu/publications/brochures/...


All questions:
What is the Reitox network?
Who are the members of the Reitox network?
What is the purpose of the EUDA NFP sub-brand logo?
What does the EUDA NFP sub-brand logo symbolise?
What is a national focal point and is there a difference with a national drugs observatory?
What is the Reitox network’s main objective, vision and values?
What is the Reitox Alliance?
How is the Reitox network managed?
What are the functions of EUDA national focal points at European level?
What types of information should EUDA national focal points provide to the EUDA and when?
What are the functions of EUDA national focal points at national level?
How should a national focal point be structured?
How many staff members should work in a national focal point and what qualifications do they need?
How are EUDA national focal points funded?
What is a ‘Reitox Academy’?
What is the assessment of EUDA national focal points?
Who can benefit from EUDA national focal points’ expertise at national level and how?
What is the added value in cooperating with the Reitox network for countries who are not members?
Where can I find the contact details of Reitox members?

Item Type
Webpage
Publication Type
International, Web Resource
Drug Type
Substances (not alcohol/tobacco)
Intervention Type
General / Comprehensive
Date
2026
Pages
12 p.
Publisher
EUDA
Corporate Creators
European Union Drugs Agency
Place of Publication
Lisbon
EndNote
Accession Number
HRB (Electronic Only)

Available Versions of this Item

Repository Staff Only: item control page